Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387058909> ?p ?o ?g. }
- W4387058909 abstract "Background: Ciprofol (HSK3486) is a novel intravenous anesthetic agent that bears structural similarity to propofol and displays favorable pharmacodynamic characteristics such as rapid onset and offset. The meta-analysis aimed at comparing the efficacy and safety of ciprofol versus propofol in clinical practice. Methods: Medline, EMBASE, Google Scholar, Cochrane Library were searched from inception to April 2023. The primary outcome was success rate of sedation/anesthetic induction and differences in sedation/induction time. The secondary outcomes included risks of hemodynamic instability, respiratory complications, and pain on injection, as well as recovery profiles, satisfaction score, and top-up dose requirement. Results: Twelve RCTs (sedation: n = 6, anesthetic induction, n = 6, all conducted in China) involving 1,793 patients (age: 34-58 years) published from 2021 to 2023 were analyzed. Pooled results revealed no differences in success rate [risk ratio (RR) = 1, 95% confidence interval (CI): 0.99 to 1.01, I2 = 0%, 1,106 patients, p = 1] and time required for successful anesthetic induction/sedation [mean difference (MD) = 7.95 s, 95% CI: -1.09 to 16.99, I2 = 97%, 1,594 patients, p = 0.08]. The risks of top-up dose requirement (RR = 0.94, p = 0.48), cardiopulmonary complications [i.e., bradycardia (RR = 0.94, p = 0.67), tachycardia (RR = 0.83, p = 0.68), hypertension (RR = 1.28, p = 0.2), hypoxemia/pulmonary depression (RR = 0.78, p = 0.24)], and postoperative nausea/vomiting (RR = 0.85, p = 0.72), as well as discharge time (MD = 1.39 min, p = 0.14) and satisfaction score (standardized MD = 0.23, p = 0.16) did not differ significantly between the two groups. However, the ciprofol group had lower risks of hypotension (RR = 0.85, p = 0.02) and pain on injection (RR = 0.17, p < 0.00001) than the propofol group. The time to full alertness was statistically shorter in the propofol group (i.e., 0.66 min), but without clinical significance. Conclusion: Our results demonstrated similar efficacy between ciprofol and propofol for sedation and anesthetic induction, while ciprofol was associated with lower risks of hypotension and pain on injection. Future studies are warranted to evaluate the efficacy and safety of ciprofol in pediatric or the elderly populations. Systematic Review Registration: (https://www.crd.york.ac.uk/prospero/), identifier (CRD42023421278)." @default.
- W4387058909 created "2023-09-27" @default.
- W4387058909 creator A5000528371 @default.
- W4387058909 creator A5002010510 @default.
- W4387058909 creator A5003281072 @default.
- W4387058909 creator A5003706528 @default.
- W4387058909 creator A5008575875 @default.
- W4387058909 creator A5014031600 @default.
- W4387058909 creator A5021227488 @default.
- W4387058909 creator A5068719939 @default.
- W4387058909 creator A5070086522 @default.
- W4387058909 date "2023-09-25" @default.
- W4387058909 modified "2023-10-12" @default.
- W4387058909 title "A systematic review and meta-analysis comparing the efficacy and safety of ciprofol (HSK3486) versus propofol for anesthetic induction and non-ICU sedation" @default.
- W4387058909 cites W1974657641 @default.
- W4387058909 cites W1993722562 @default.
- W4387058909 cites W1996435587 @default.
- W4387058909 cites W1999952164 @default.
- W4387058909 cites W2002768687 @default.
- W4387058909 cites W2024476766 @default.
- W4387058909 cites W2034880004 @default.
- W4387058909 cites W2037199501 @default.
- W4387058909 cites W2082494913 @default.
- W4387058909 cites W2274072963 @default.
- W4387058909 cites W2287217605 @default.
- W4387058909 cites W2606832143 @default.
- W4387058909 cites W2809427753 @default.
- W4387058909 cites W2883595456 @default.
- W4387058909 cites W2884882031 @default.
- W4387058909 cites W2888480142 @default.
- W4387058909 cites W2909891606 @default.
- W4387058909 cites W2928581296 @default.
- W4387058909 cites W2970684805 @default.
- W4387058909 cites W2990264484 @default.
- W4387058909 cites W3026008272 @default.
- W4387058909 cites W3153481290 @default.
- W4387058909 cites W3165579330 @default.
- W4387058909 cites W3169796663 @default.
- W4387058909 cites W4200616521 @default.
- W4387058909 cites W4212788764 @default.
- W4387058909 cites W4214827558 @default.
- W4387058909 cites W4220810545 @default.
- W4387058909 cites W4220932528 @default.
- W4387058909 cites W4281707865 @default.
- W4387058909 cites W4283326984 @default.
- W4387058909 cites W4284891260 @default.
- W4387058909 cites W4285728770 @default.
- W4387058909 cites W4289645900 @default.
- W4387058909 cites W4289711996 @default.
- W4387058909 cites W4303646463 @default.
- W4387058909 cites W4313400113 @default.
- W4387058909 cites W4313499850 @default.
- W4387058909 cites W4316672682 @default.
- W4387058909 cites W4317498770 @default.
- W4387058909 cites W4317664027 @default.
- W4387058909 cites W4319767756 @default.
- W4387058909 cites W4321250622 @default.
- W4387058909 cites W4324017593 @default.
- W4387058909 cites W4360820072 @default.
- W4387058909 doi "https://doi.org/10.3389/fphar.2023.1225288" @default.
- W4387058909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37818194" @default.
- W4387058909 hasPublicationYear "2023" @default.
- W4387058909 type Work @default.
- W4387058909 citedByCount "0" @default.
- W4387058909 crossrefType "journal-article" @default.
- W4387058909 hasAuthorship W4387058909A5000528371 @default.
- W4387058909 hasAuthorship W4387058909A5002010510 @default.
- W4387058909 hasAuthorship W4387058909A5003281072 @default.
- W4387058909 hasAuthorship W4387058909A5003706528 @default.
- W4387058909 hasAuthorship W4387058909A5008575875 @default.
- W4387058909 hasAuthorship W4387058909A5014031600 @default.
- W4387058909 hasAuthorship W4387058909A5021227488 @default.
- W4387058909 hasAuthorship W4387058909A5068719939 @default.
- W4387058909 hasAuthorship W4387058909A5070086522 @default.
- W4387058909 hasBestOaLocation W43870589091 @default.
- W4387058909 hasConcept C126322002 @default.
- W4387058909 hasConcept C2776277131 @default.
- W4387058909 hasConcept C2776478404 @default.
- W4387058909 hasConcept C2776779939 @default.
- W4387058909 hasConcept C2776814716 @default.
- W4387058909 hasConcept C2777495988 @default.
- W4387058909 hasConcept C2777953023 @default.
- W4387058909 hasConcept C2778162923 @default.
- W4387058909 hasConcept C2780580376 @default.
- W4387058909 hasConcept C42219234 @default.
- W4387058909 hasConcept C44249647 @default.
- W4387058909 hasConcept C71924100 @default.
- W4387058909 hasConcept C82789193 @default.
- W4387058909 hasConcept C84393581 @default.
- W4387058909 hasConcept C95190672 @default.
- W4387058909 hasConceptScore W4387058909C126322002 @default.
- W4387058909 hasConceptScore W4387058909C2776277131 @default.
- W4387058909 hasConceptScore W4387058909C2776478404 @default.
- W4387058909 hasConceptScore W4387058909C2776779939 @default.
- W4387058909 hasConceptScore W4387058909C2776814716 @default.
- W4387058909 hasConceptScore W4387058909C2777495988 @default.
- W4387058909 hasConceptScore W4387058909C2777953023 @default.
- W4387058909 hasConceptScore W4387058909C2778162923 @default.
- W4387058909 hasConceptScore W4387058909C2780580376 @default.
- W4387058909 hasConceptScore W4387058909C42219234 @default.